MARKHAM, Ontario --(BUSINESS WIRE)--Dec. 10, 2024-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by Health Canada , in-warranty t:slim X2™ insulin pump users can now access full compatibility with both the Dexcom G7 and
SAN DIEGO --(BUSINESS WIRE)--Nov. 21, 2024-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: 36 th Annual Piper Sandler Healthcare Conference
SAN DIEGO --(BUSINESS WIRE)--Nov. 6, 2024-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2024 and increased sales guidance for the year ending December 31, 2024 .
SAN DIEGO --(BUSINESS WIRE)--Oct. 30, 2024-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will host meetings and present a company update at the following investor conferences: UBS Global Healthcare Conference
SAN DIEGO --(BUSINESS WIRE)--Oct. 2, 2024-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2024 results after the financial markets close on Wednesday, November 6, 2024 .
SAN DIEGO --(BUSINESS WIRE)--Sep. 19, 2024-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2 insulin pump with Control-IQ automated insulin delivery (AID) technology is now cleared for use with Eli Lilly and
SAN DIEGO --(BUSINESS WIRE)--Aug. 26, 2024-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will host meetings and present a company update at the following investor conferences: 2024 Wells Fargo Healthcare
SAN DIEGO --(BUSINESS WIRE)--Aug. 19, 2024-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM) today announced the planned release of version 2.8.2 of its Apple iOS t:connect mobile app in the United States on August 20, 2024 to correct an issue described in a March 2024 recall that can cause rapid
SAN DIEGO --(BUSINESS WIRE)--Aug. 12, 2024-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM) today provided an update on the March 2024 recall of its Apple iOS t:connect mobile app in the United States relating to an issue that can cause rapid depletion of a user’s t:slim X2 insulin pump battery.
SAN DIEGO --(BUSINESS WIRE)--Aug. 1, 2024-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2024 and increased sales guidance for the year ending December 31, 2024 .
SAN DIEGO --(BUSINESS WIRE)--Jul. 30, 2024-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the Canaccord Genuity 44 th Annual Growth Conference on Tuesday, August 13, 2024 at
– Only Automated Insulin Delivery System in Canada to Feature Both Dexcom G7 and G6 CGM Technology Now Authorized for Sale by Health Canada – MARKHAM, Ontario --(BUSINESS WIRE)--Jul. 29, 2024-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc.
SAN DIEGO --(BUSINESS WIRE)--Jul. 11, 2024-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2024 results after the financial markets close on Thursday, August 1, 2024 .
SAN DIEGO --(BUSINESS WIRE)--Jun. 22, 2024-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today presented new real-world insights from a survey on Tandem Mobi user satisfaction and wearability during the 84th Scientific Sessions of the
SAN DIEGO --(BUSINESS WIRE)--Jun. 20, 2024-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Jean-Claude “JC” Kyrillos as Executive Vice President and Chief Operating Officer, effective June 21, 2024 . Mr.
SAN DIEGO --(BUSINESS WIRE)--Jun. 18, 2024-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced its schedule of presentations for the American Diabetes Association’s (ADA) 84th Scientific Sessions taking place in Orlando, Florida
SAN DIEGO --(BUSINESS WIRE)--May 29, 2024-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. (Nasdaq: DXCM), today announced that the Tandem Mobi insulin pump with Control-IQ technology is now fully compatible with both the Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM)
SAN DIEGO --(BUSINESS WIRE)--May 23, 2024-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 8:00am Eastern
SAN DIEGO --(BUSINESS WIRE)--May 2, 2024-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2024 and increased sales guidance for the year ending December 31, 2024 .
SAN DIEGO --(BUSINESS WIRE)--Apr. 29, 2024-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: BofA Securities Health Care Conference 2024 on
